Impact of oral early antiviral therapies for mild–moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis

Impact of oral early antiviral therapies for mild–moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis

Abstract Background Molnupiravir (MOL) and nirmatrelvir/ritonavir (NIR) decreased mortality and hospital admissions in high-risk patients with mild to moderate COVID-19. Nevertheless, there is a lack of data about the pharmacoeconomic impact of these antivirals in the Omicron era. We conducted a pha...

Full description

Saved in:
Bibliographic Details
Main Authors: Vincenzo Scaglione, Samuele Gardin, Lolita Sasset, Nicolò Presa, Alberto Rossetto, Deris Gianni Boemo, Sofia Silvola, Umberto Restelli, Annamaria Cattelan
Format: Article
Language:English
Published: BMC 2024-12-01
Series:European Journal of Medical Research
Online Access:https://doi.org/10.1186/s40001-024-02154-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40001-024-02154-2

Similar Items